Supported by the Italian Ministry of Research (PRIN), Istituto Pasteur – Fondazione Cenci Bolognetti, La Sapienza University (Ateneo Federato).
NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD†
Article first published online: 31 JAN 2012
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 10, pages 1910–1922, October 2012
How to Cite
La Scaleia, R., Stoppacciaro, A., Oliva, S., Morrone, S., Di Nardo, G., Santoni, A., Cucchiara, S. and Palmieri, G. (2012), NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD. Inflamm Bowel Dis, 18: 1910–1922. doi: 10.1002/ibd.22899
- Issue published online: 13 SEP 2012
- Article first published online: 31 JAN 2012
- Manuscript Accepted: 3 JAN 2012
- Manuscript Received: 13 NOV 2011
- γ/δ T cells;
- CD56+ T cells;
Dysregulated innate immune responses play an important role in inflammatory bowel disease (IBD). NKG2D innate immunity receptor is a major sensor of tissue damage that, by recognizing multiple stress-induced, cell-associated ligands (MIC-A/B and ULBP1-5), potentiates the effector functions of “innate-like” (γ/δ TcR+, and natural killer receptor+ [NKR+]) T-cell populations. We analyzed the representivity, NKG2D/ligand expression pattern, and functional ability of the major innate immunity cell populations in pediatric IBD patients.
We analyzed 41 Crohn's disease (CD) patients, 33 ulcerative colitis (UC) patients, and 51 age-matched non-IBD controls. The expression of NKG2D and its ligands, interferon-gamma (IFN-γ) production, and cytotoxic granule release were assessed by immunostaining and multiparameter cytofluorimetric analysis on circulating and mucosal mononuclear subsets; the inflammatory infiltrate was also characterized by immunohistochemistry.
The expression pattern of NKG2D receptor and its ligands on mucosal and circulating innate immunity populations is severely disturbed in IBD; NKG2D and ligands are upregulated on immune infiltrate in both CD and UC active lesions; receptor/ligand upregulation also occurs on circulating leukocyte populations, where it depends on both disease activity and type (UC vs. CD). Finally, the frequency and effector capability of peripheral blood “innate-like” T-cell populations are also altered in IBD patients.
The circulating and mucosal innate immunity compartment is phenotypically and functionally altered in pediatric IBD; some alterations may represent a distinctive feature of the pediatric disease condition. The disturbance of NKG2D/ligand pathway may play a role in sustaining immune activation which leads to chronic inflammatory tissue damage. (Inflamm Bowel Dis 2012)